Madrigal Pharmaceuticals, Inc. MDGL Return on invested capital

Return on invested capital at other companies

Eli LillyLLY

39.7%+10.3pp

Gyre Therapeutics, Inc.GYRE

-0.1%-19.4pp

AltimmuneALT

-61.7%-17.9pp

Viking TherapeuticsVKTX

-59.2%-292pp

Arrowhead ResearchARWR

-38.8%+135pp

Mirum Pharmaceuticals, Inc.MIRM

-43.3%—

FAQ

What is Madrigal Pharmaceuticals, Inc.'s return on invested capital?

Madrigal Pharmaceuticals, Inc. (MDGL) reported return on invested capital of -51.7% in Q2 2026.

How has Madrigal Pharmaceuticals, Inc.'s return on invested capital changed year-over-year?

Madrigal Pharmaceuticals, Inc.'s return on invested capital increased by 5.9% year-over-year, from -54.9% to -51.7%.

What is the long-term trend for Madrigal Pharmaceuticals, Inc.'s return on invested capital?

Over 3 years (2020 to 2025), Madrigal Pharmaceuticals, Inc.'s return on invested capital has grown at a -18.9% compound annual growth rate (CAGR), from -74.2% to -39.6%.

What does return on invested capital mean?

Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.